Loading stock data…
Korro Bio (KRRO)
$13.20+0.49 (+3.90%)
Market ClosedLast close Jun 29
Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Korro Bio, Inc. in the Healthcare sector is trading at $13.20 with a market capitalization of $155M. Wall Street consensus targets $20.00 (10 analysts), implying a +51.6% move over the next 12 months. The stock is currently near its 52-week low of $5.20, remaining 23.1% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +51.6% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0↓ | $1.29M↑ | $1.09M↓ | $1.46M↓ | $2.55M |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$20.44M↓ | -$15.88M↑ | -$19.24M↑ | -$27.20M↓ | -$25.02M |
| Net Income | -$19.63M↑ | -$50.04M↓ | -$18.06M↑ | -$25.77M↓ | -$23.39M |
Peer Comparison
JNJUNHPFE
Fundamentals
Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead produ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$155.33M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-94.87%
Volume
Today's trading volume
164,647
Recent News
Korro Bio, Inc. (KRRO) Soars 17.6%: Is Further Upside Left in the Stock?
Korro Bio, Inc. (KRRO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
One Korro Bio Insider Raised Stake By 19% In Previous Year
Viewing insider transactions for Korro Bio, Inc.'s ( NASDAQ:KRRO ) over the last year, we see that insiders were net...
What Makes Korro Bio, Inc. (KRRO) a New Buy Stock
Korro Bio, Inc. (KRRO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Top 5 Insider Buys From Q1: Buy, Sell, or Hold in Q2?
Insiders aggressively bought these stocks, signaling confidence in their operations. The question is whether others think the same.
Korro Bio, Inc. (KRRO) Reports Q4 Loss, Lags Revenue Estimates
Korro Bio, Inc. (KRRO) delivered earnings and revenue surprises of -175.08% and -13.87%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?